The global medical dry fluorescence immunoassay analyzer market is projected to grow at a CAGR of 14.5% during the forecast period. The dry fluorometric immunoassay analyzer offers the precise and quick quantitative analysis of analytes present in whole blood, serum, urine and others. The product mostly used for the diagnosis of chronic disorders such as diabetes, thyroid hormones, and recently, the product demand also surges in the diagnosis of COVID 19 patients. The product seen in diagnosing the COVID 19 cases more accurately is also considered one of the supporting factors which boost the growth of medical dry fluorescence immunoassay analyzer industry. Rising governmental and non-government investment in the area of research increasing the demand for such devices in the medical devices industry.

Adroit Market Research report on global medical dry fluorescence immunoassay analyzer market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for the period 2018 to 2028, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with Porter's five forces analysis and company positioning based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global medical dry fluorescence immunoassay analyzer market have been studied in detail.

The dry fluorescence immunoassay analyze market is in high demand product. Each region across the world shows a speedy rise in the corona 19 patients followed by chronic disorders. North America dominates the global dry fluorescence immunoassay analyze market. The United States holds the major market in the region followed by Europe. The rising geriatric population in America, Europe and Asia Pacific is the major driving factor for the growth of the market.

The prominent players operating in global medical dry fluorescence immunoassay analyzer market include AESKU.SYSTEMS GmbH and Co. KG, Alere San Diego, Inc., Astute Medical, Inc., Boditech Med Inc., NanoEnTek Inc., Phadia AB, Quidel Corporation, Radiometer Medical ApS, Thermo Fisher Scientific Inc., Wako Pure Chemical Industries, Ltd, Wallac Oy, Lansionbio, Labism, ReLIA Biotech among other prominent players.

Key segments of the global Medical Dry Fluorescence Immunoassay Analyzer market

Product Overview, 2018-2028 (USD Billion)

• Multi-Channel
• Single Channel

Application Overview, 2018-2028 (USD Billion)

• Clinic
• Research
• Others

Regional Overview, 2018-2028 (USD Billion)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• South America
  • Brazil
  • Mexico
  • Rest of South America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East and Africa